Chamomile: The Definitive Guide

What is Chamomile?

Chamomile tea, flower powder and standardized extracts are different exposures. Sleep evidence is mixed, and the best-known chronic-insomnia trial was small and null on its primary sleep-diary outcomes. NCCIH says reliable evidence is insufficient for most chamomile uses and highlights very little insomnia research. Allergy can be serious, especially in people allergic to ragweed, chrysanthemums, marigolds or daisies. [1]

Typical Chamomile Protocols

These rows reproduce sources. Do not average them into one universal regimen.

Which forms and label details matter?

Record German chamomile or Roman chamomile, Latin species, flower versus another plant part, tea versus powder or extract, extraction ratio, solvent and marker standardization. The Zick insomnia study used three 90 mg tablets at each administration. Each tablet was specified as at least 2.5 mg apigenin and later measured at 3.9 mg, so even its labeled and analyzed marker amounts were not identical. That 6:1 extract is not equivalent to an unspecified tea bag or isolated apigenin.

How should it be stored?

Follow the finished-product label. Keep the container closed, dry and protected from heat and light; teas, tinctures and extracts can have different storage directions.

What is it commonly used for?

Chamomile is used for relaxation, sleep, anxiety and digestive discomfort. Trials for insomnia, general sleep quality and diagnosed generalized anxiety disorder answer different questions and should not be merged into a universal calming claim.

What does human research show?

Zick randomized 34 adults with at least six months of primary insomnia to 270 mg twice daily or placebo. After 28 days, total sleep time, sleep efficiency, sleep latency, wake after sleep onset, sleep quality and awakenings did not differ significantly. Daytime-function differences also missed statistical significance, and the total-sleep-time effect size favored placebo. [2] A 2024 systematic review included 10 studies and 772 participants. Five PSQI studies pooled to a 1.88-point improvement, but heterogeneity was very high (I² 88.4%); sleep duration, sleep efficiency and daytime functioning were not consistently improved, and product testing and blinding assessment were uncommon. Its statement that no adverse events were reported is weakened by mostly passive surveillance. [3] A 60-person single-blind older-adult trial using 200 mg twice daily reported better PSQI scores after 28 days, but the setting, blinding, subjective endpoint and incompletely reported extract limit generalization. [4] Anxiety evidence is separate: an eight-week 57-person GAD trial used response-based titration from 220 mg to 1,100 mg/day and found a modest HAM-A signal. A later responder-enriched study used 500 mg three times daily; its primary relapse comparison was not significant (hazard ratio 0.52, 95% CI 0.20–1.33). [5][6]

How might it act?

Chamomile is a mixture of flavonoids and volatile constituents rather than a single sedative molecule. Apigenin can interact with gamma-aminobutyric acid (GABA) receptor systems in laboratory models, while alpha-bisabolol and other compounds provide different possible pathways. Human trials did not measure brain receptor activity or identify one constituent as the cause of an outcome. The extract, its measured marker compounds and isolated apigenin therefore remain separate exposures.

How does it compare with related products?

What are the risks and interactions?

Tea and food amounts are generally well tolerated, but concentrated products can cause nausea, dizziness and allergic reactions, including rare anaphylaxis. Cross-reaction risk is higher with allergy to ragweed-family plants. Review warfarin, sedatives and medicines with narrow exposure margins; reported or theoretical interactions are not a universal separation schedule. Safety during pregnancy and breastfeeding is not established. [1]

Which medicines require review?

Review warfarin and other anticoagulants, sedatives, alcohol, allergy medicines and drugs whose exposure could change through hepatic metabolism. Seek urgent care for trouble breathing, facial swelling or widespread hives.

Regulatory status: In the United States, supplements generally lack premarket efficacy approval. In Canada, verify the finished product’s NPN or DIN-HM and licensed conditions. [7], [8]

What should be monitored?

Record product, lot, form, amount per administration, frequency, daily total, co-ingredients, meals, symptoms, medicines, chosen outcome and review date.

What happens when it is stopped?

No ingredient-specific withdrawal syndrome is established. Record the stop date and compare the same sleep and next-day measures rather than changing several products at once.

Seek prompt care for a serious allergic reaction, unusual bleeding, persistent palpitations, chest pain or another severe symptom.

What do public communities report?

Public reports commonly mention relaxation, vivid dreams, morning grogginess or no effect. Those reports rarely verify species, extract, co-ingredients or sleep diagnosis, so they generate tracking questions rather than efficacy estimates.

Common questions about Chamomile

Did the best-known insomnia trial improve sleep?

No. None of its primary sleep-diary outcomes differed significantly after 28 days.

Why can a meta-analysis look positive when that trial was null?

The review pooled different populations and preparations; its PSQI result had very high heterogeneity.

Is chamomile tea equivalent to the studied capsules?

No. Species, flower amount, extraction and marker content differ.

Is chamomile the same as apigenin?

No. Chamomile contains many constituents, and extract results cannot be assigned to isolated apigenin.

Who should take allergy precautions?

People allergic to ragweed, chrysanthemums, marigolds, daisies or chamomile should review use before exposure.

What should I track?

Species, tea or extract, amount each time, timing, allergy symptoms, sleep latency, awakenings, total sleep and next-day function.

Glossary

Terms for reading the evidence.

Preparation identity

Species or compound, plant part, extraction, ratio and standardization that define the tested product.

Amount per administration

Amount consumed at one time, distinct from daily total.

PSQI

Pittsburgh Sleep Quality Index, a self-reported questionnaire rather than an objective sleep recording.

ISI

Insomnia Severity Index, a symptom questionnaire used to rate perceived insomnia severity.

Monotherapy

The ingredient was tested without another active intervention.

Traditional use

A regulatory category based on long-standing use; it is not equivalent to efficacy established by modern randomized trials.

How this guide was researched

Accessible official sources and human reports were read on October 9, 2026. Titles, authors, journals, DOI, PMID and visible corrections were checked. An unreported frequency was not guessed.

How this guide was made

Research and drafting were AI-assisted. This draft awaits Doserly editorial review and independent clinical review. See the editorial policy.

Explore the sources